Abstract:The transforming growth factor receptor III (TβRIII) is commonly recognized as a co-receptor that promotes the binding of TGFβ family ligands to type I and type II receptors. Within the immune system, TβRIII regulates T cell development in the thymus and is differentially expressed through activation; however, its function in mature T cells is unclear. To begin addressing this question, we developed a conditional knock-out mouse with restricted TβRIII deletion in mature T cells, necessary because genomic deletion of TβRIII results in perinatal mortality. We determined that TβRIII null mice developed more severe autoimmune central nervous neuroinflammatory disease after immunization with myelin oligodendrocyte peptide (MOG 35-55 ) than wild-type littermates. The increase in disease severity in TβRIII null mice was associated with expanded numbers of CNS infiltrating IFNγ + CD4 + T cells and cells that co-express both IFNγ and IL-17 (IFNγ + /IL-17 + ), but not IL-17 alone expressing CD4 T cells compared to Tgfbr3 fl/fl wild-type controls. This led us to speculate that TβRIII may be involved in regulating conversion of encephalitogenic Th17 to Th1. To directly address this, we generated encephalitogenic Th17 and Th1 cells from wild type and TβRIII null mice for passive transfer of EAE into naïve mice. Remarkably, Th17 encephalitogenic T cells from TβRIII null induced EAE of much greater severity and earlier in onset than those from wild-type mice. The severity of EAE induced by encephalitogenic wild-type and Tgfbr3 fl/fl .dLcKCre Th1 cells were similar. Moreover, in vitro restimulation of in vivo primed Tgfbr3 fl/fl .dLcKCre T cells, under Th17 but not Th1 polarizing conditions, resulted in a significant increase of IFNγ + T cells. Altogether, our data indicate that TβRIII is a coreceptor that functions as a key checkpoint in controlling the pathogenicity of autoreactive T cells in neuroinflammation probably through regulating plasticity of Th17 T cells into pathogenic Th1 cells. Importantly, this is the first demonstration that TβRIII has an intrinsic role in T cells.

Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.

EncephalomyelitisDevelopment of Autoimmune Mice Lead to Marginally Enhanced Responses in EBV-Induced Gene 3-Deficient Increased Th17 and Regulatory T Cell

Enhanced T cell proliferation, Th17 differentiation and unaltered IL-10 production lead to marginally enhanced development of experimental autoimmune encephalomyelitis in EBI3-deficient mice (114.12)

Epstein-Barr Virus-Induced Gene 3-Deficiency Leads To Impaired Antitumor T-Cell Responses And Accelerated Tumor Growth

Epstein Barr Virus-Induced 3 (EBI3) Together with IL-12 Negatively Regulates T Helper 17-Mediated Immunity to Listeria Monocytogenes Infection.

Interleukin-33 is Released in Spinal Cord and Suppresses Experimental Autoimmune Encephalomyelitis in Mice.

Role of IL-12 Receptor β1 in Regulation of T Cell Response by APC in Experimental Autoimmune Encephalomyelitis

Induction of Experimental Autoimmune Encephalomyelitis in Il-12 Receptor-Beta 2-Deficient Mice: Il-12 Responsiveness is Not Required in the Pathogenesis of Inflammatory Demyelination in the Central Nervous System

[Expression of EBI3 and P28 Mrna in the Brain and Spinal Cord of Chronic Model of Experimental Autoimmune Encephalomyelitis in C57BL/6J Mice].

Suppressive Effect of Il-27 on Encephalitogenic Th17 Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis

Il-9 is Important for T-Cell Activation and Differentiation in Autoimmune Inflammation of the Central Nervous System

Transforming growth factor receptor III (Betaglycan) regulates the generation of pathogenic Th17 cells in EAE

IL-21 Modulates CD4+ CD25+ Regulatory T-cell Homeostasis in Experimental Autoimmune Encephalomyelitis.

T cell restricted TGF-βR3 (betaglycan) null mice develop exacerbated experimental autoimmune encephalomyelitis (EAE) associated with expanded generation of Th1 cells

IFN-β Regulates Th17 Differentiation Partly Through the Inhibition of Osteopontin in Experimental Autoimmune Encephalomyelitis.

Independent and Interdependent Immunoregulatory Effects of IL-27, IFN-β, and IL-10 in the Suppression of Human Th17 Cells and Murine Experimental Autoimmune Encephalomyelitis.

Increased regulatory activity of intestinal innate lymphoid cells type 3 (ILC3) prevents experimental autoimmune encephalomyelitis severity

Baff Promotes Th17 Cells And Aggravates Experimental Autoimmune Encephalomyelitis

NFIL3 Deficiency Alleviates EAE Through Regulating Different Immune Cell Subsets.

Interleukin-27 Gene Therapy Prevents the Development of Autoimmune Encephalomyelitis but Fails to Attenuate Established Inflammation Due to the Expansion of CD11b+Gr-1+ Myeloid Cells

Mouse Cd11b(+)Gr-1(+) Myeloid Cells Can Promote Th17 Cell Differentiation And Experimental Autoimmune Encephalomyelitis